Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Fabio D. Mataveli"'
1
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Intravenous Doses of IGN002 Administered Weekly to Subjects with Refractory Non-Hodgkin Lymphoma
Autor: Fabio D. Mataveli, Patricia A. Young
Publikováno v: Blood. 136:35-35
Background:Non-Hodgkin lymphoma (NHL) is the most common, adult hematologic malignancy. Despite available treatment, relapse rates are high and novel therapies are warranted. IGN002 consists of an anti-CD20 monoclonal antibody (mAb) fused to interfer
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::14dc33a19829f1a8ef8b53f9f21cc57b
https://doi.org/10.1182/blood-2020-137784
Zobrazit plný text záznamu
2
Células envolvidas no remodelamento da matriz extracelular após infarto agudo do miocárdio
Autor: Thérèse Rachell Theodoro, Fabio D. Mataveli, Ana Maria Amaral Antonio Mader, Larissa Ferraz Garcia, Maria Aparecida da Silva Pinhal, Giselle Z. Justo
Publikováno v: Einstein (São Paulo), Volume: 13, Issue: 1, Pages: 89-95, Published: MAR 2015
Einstein (São Paulo), Vol 13, Iss 1, Pp 89-95
Einstein
einstein (São Paulo) v.13 n.1 2015
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
Objective Evaluate the effects of VEGF165 gene transfer in the process of remodeling of the extracellular matrix after an acute myocardial infarct. Methods Wistar rats were submitted to myocardial infarction, after the ligation of the left descending
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc6487b0cf1c3c86e5d565b832955dea
https://doi.org/10.1590/s1679-45082015ao2970
Zobrazit plný text záznamu
4
Análise de custo-efetividade de análogos da somatostatina no tratamento de acromegalia no Brasil
Autor: Fabio D. Mataveli, Vanessa Q. Passos, Alessandra Calabró, Joice Valentim
Publikováno v: Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 52, Issue: 9, Pages: 1452-1460, Published: DEC 2008
Arquivos Brasileiros de Endocrinologia & Metabologia v.52 n.9 2008
Arquivos Brasileiros de Endocrinologia & Metabologia
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
O objetivo deste estudo é comparar o impacto econômico e o impacto nos pacientes com acromegalia do tratamento com dois diferentes análogos de somatostatina (octreotida LAR e lanreotide SR) no Brasil. Um estudo de custoefetividade foi realizado a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::796f8710afd98b2de576d05947ae47d2
http://repositorio.unifesp.br/handle/11600/4737
Zobrazit plný text záznamu
5
Glycosaminoglycan synthesis and shedding induced by growth factors are cell and compound specific
Autor: Angela S. Nohara, Maria Aparecida da Silva Pinhal, Eloah Rabello Suarez, Leandro Luongo de Matos, Helena B. Nader, Fabio D. Mataveli
Publikováno v: Growth factors (Chur, Switzerland). 25(1)
The interactions between growth factors and sulphated glycosaminoglycans (GAG) have been extensively studied. The aim of this study is to investigate if growth factors would show specificity of action on the synthesis and shedding of sulphated GAG, u
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b084231c1453d1a5e7a9755e06913b
https://pubmed.ncbi.nlm.nih.gov/17454150
Zobrazit plný text záznamu
6
234. Long Term Effects of pcDNA3_VEGF165 Intramyocardial Transfer after Experimental Myocardial Infarction in the Rat Scar Tissue Extracellular Matrix
Autor: Aline Mendes, Helena B. Nader, Fabio D. Mataveli, Sang Won Han, Maria Aparecida da Silva Pinhal, Paulo José Ferreira Tucci, Rose Kanashiro
Publikováno v: Molecular Therapy. 13
Introduction: After the acute occlusion of a coronary artery, a considerable number of growth factors (GF) are released at the infarct site, triggered by the inflammatory process and the ischemic condition. In this process to compensate regional isch
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300a10d654ef120811684ddbfb74a026
Zobrazit plný text záznamu
7
The Treatment Cost To Achieve a Complete Cytogenetic Response in Imatinib Resistant Chronic Phase (CP) Chronic Myelogenous Leukemia (CML) Patients: Nilotinib vs. Dasatinib
Autor: Fabio D. Mataveli, Vania Hungria, Alessandra Calabró, Wellington Mendes, Weiwei Feng
Publikováno v: Blood. 110:3327-3327
BACKGROUND: Imatinib (IM) has revolutionized the treatment of CML. The 5-year-survival rate of 89% for CML-CP and improving long-term tolerability profile made IM the first choice for CP-CML treatment. However, a subset of patients may become resista
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ce7afbe9fae4956ce1129c7e0feb69e
https://doi.org/10.1182/blood.v110.11.3327.3327
Zobrazit plný text záznamu
8
Cost-Effectiveness of Imatinib Versus Interferon-α in the Treatment of Patients Newly Diagnosed with Chronic Myeloid Leukemia, under the Brazilian Public Healthcare System Perspective
Autor: Wellington Mendes, Pedro Enrique Dorlhiac-Llacer, Ricardo Bigni, Vania Hungria, Alessandra Calabró, Denizar Vianna, Fabio D. Mataveli
Publikováno v: Blood. 108:3314-3314
The 60-month follow-up data for patients randomized to imatinib in IRIS demonstrated significant clinical improvements in survival rates and QALYs gained (17,09 years;13,58 QALYs) in patients newly diagnosed with chronic myeloid leukemia (CML) and tr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bc98e9ba78c52f5fb41326e8bb78ec7a
https://doi.org/10.1182/blood.v108.11.3314.3314
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje